Applications for 2013 Dr. Charles A. Sanders/Project HOPE International Residency Scholarship Now Being Accepted
Applications are now being accepted for the 2013 Dr. Charles A. Sanders/Project HOPE International Residency Scholarship funded by the North Carolina GlaxoSmithKline Foundation.
Millwood, VA, January 16, 2013
Applications are now being accepted for the 2013 Dr. Charles A. Sanders/Project HOPE International Residency Scholarship funded by the North Carolina GlaxoSmithKline Foundation. The scholarship program enables current medical residents from the state of North Carolina to participate in a one- to two-month supervised global health elective at one of Project HOPE’s program sites in the developing world.
The highly-competitive scholarship is open to applicants who have completed at least one year of postgraduate training in any specialty at one of North Carolina’s four medical schools – Wake Forest University, Duke University, the Brody School of Medicine at East Carolina University and the University of North Carolina at Chapel Hill. Applicants are expected to demonstrate an interest and commitment to the practice of medicine in a low-resource international setting. Residents are selected annually as Sanders Scholars.
The sites selected for 2013 are Monte Plata, Dominican Republic and Vijayawada, India (Andhra Pradesh). In Vijayawada, India, the scholarship recipient(s) would be interning at the NRI General Hospital, assigned to the designated specialty of the recipient. In the Dominican Republic, the scholarship recipient(s) would be interning at the Monte Plata Clinic, where high quality maternal and child health care are provided at low cost.
“Project HOPE is thrilled to be a part of this unique effort to enable North Carolina’s most talented young physicians to make a difference in the health of underserved communities in the developing world,” said John P. Howe III, M.D., President and CEO of Project HOPE. “I know this experience will have a lasting impact on the physicians as they learn in these new practice settings in countries far from the U.S.”
Charles A. Sanders, M.D., for whom the scholarship is named, is the retired Chairman and CEO of Glaxo Inc., a global health care company. He served as Chairman of the Board of Directors of Project HOPE for 18 years. As Chairman, his leadership was instrumental in HOPE’s involvement with establishing the Shanghai Children’s Medical Center in China, a hospital specializing in pediatric cardiac surgeries, as well as the Basra Children’s Hospital in Basra, Iraq. Throughout his career, Dr. Sanders has been committed to improving access to quality medical care in underserved communities throughout the world. Dr. Sanders currently serves as Chairman Emeritus at Project HOPE.
The application deadline is February 28. Finalist candidates will be selected and initial interviews will be conducted by phone in March. An awardee or awardees will be announced on April 1. The Sanders scholarship will fund all expenses related to the elective such as costs of preparation and orientation, insurance, airfare and an in-country daily stipend. For more information on the residency scholarship and to download an application, please visit http://www.projecthope.org/scholarship.
Check out the NC NOW, UNC-TV Interview with Dr. Meredith Miller, the first-ever Dr. Charles Sanders International Residency Scholar.
About Project HOPE
Founded in 1958, Project HOPE (Health Opportunities for People Everywhere) is dedicated to providing lasting solutions to health problems with the mission of helping people to help themselves. Identifiable to many by the SS HOPE, the world’s first peacetime hospital ship, Project HOPE now provides medical training and health education, as well as conducts humanitarian assistance programs in more than 35 countries.
Project HOPE currently works with program sites in Latin American and the Caribbean, sub-Saharan Africa, China and Southeast Asia, Russia/Eurasia, and the Middle East. Follow us on Twitter @projecthopeorg
About The North Carolina GlaxoSmithKline Foundation
Based in Research Triangle Park, the North Carolina GlaxoSmithKline Foundation supports programs that promote the sciences, health, and education. Since its creation in 1986, the Foundation has granted more than $60 million to support North Carolina projects and programs that meet the educational needs of today’s society and of future generations. Follow us on Twitter @NCGSKFound.
Geraldine Carroll (540) 257-3746 or [email protected]